Ads
related to: global initiative for asthma guidelines 2020 pdf- Home
Official Patient Website—
Get Treatment Info Today.
- Register For A Webinar
Learn From Medical Professionals
Hear From Real Patients Like You
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Sign Up
Register Or Activate Your Card—
Find Out If You're Eligible Today.
- Home
Search results
Results From The WOW.Com Content Network
Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...
The Global Initiative for Asthma (GINA) is a medical guidelines organisation which works with public health officials and health care professionals globally to reduce asthma prevalence, morbidity, and mortality. GINA was launched in 1993 as a collaboration between National Heart, Lung, and Blood Institute, National Institutes of Health, and the ...
Epidemiology of asthma. Rates of asthma rates in 2017 [1] As of 2011, approximately 235 million people worldwide were affected by asthma, [2] and roughly 250,000 people die per year from asthma-related causes. [3] Low and middle income countries make up more than 80% of the mortality. [4]
Various asthma guidelines, such as the Global Initiative for Asthma Guidelines [GINA], the British Guidelines on the management of Asthma, The Canadian Pediatric Asthma Consensus Guidelines, and United States Guidelines for Diagnosis and Treatment of Asthma each recommend metered dose inhalers in place of nebulizer-delivered therapies. [3]
Such a treatment scheme is consistent with the widely adopted guidelines for the management and prevention of asthma, issued by Global Initiative of Asthma (GINA), which was a medical guidelines organization launched in 1993 in collaboration with the National Heart, Lung, and Blood Institute, National Institutes of Health, US, and the World ...
Salmeterol is a long-acting β 2 adrenergic receptor agonist (LABA) used in the maintenance and prevention of asthma symptoms and maintenance of chronic obstructive pulmonary disease (COPD) symptoms. [2] Symptoms of bronchospasm include shortness of breath, wheezing, coughing and chest tightness. It is also used to prevent breathing ...
Ad
related to: global initiative for asthma guidelines 2020 pdf